Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 96 citing articles:

Analysis of reoperational reason of patients with thyroid cancer and strategies for its diagnosis and treatment: A 6‐year single‐center retrospective study
Rongli Xie, Yawei Feng, Jiankang Shen, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Global trend and disparity in the burden of thyroid cancer attributable to high body-mass index from 1990 to 2021 and projection to 2049: a systematic analysis based on the Global Burden of Disease Study 2021
Ying Chen, Han-zhang Hong, Zhenhua Gao, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Male Thyroid Cancer Patients Treated by Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA): Surgical Outcomes and Distinct Experiences
Hau Xuan Nguyen, Hien Xuan Nguyen, Tan N. Nguyen, et al.
Indian Journal of Surgical Oncology (2025)
Closed Access
Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity
Lisa J. Zhang, Yin Xiong, Naris Nilubol, et al.
Carcinogenesis (2015) Vol. 36, Iss. 4, pp. 420-428
Open Access | Times Cited: 35
Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer
Fu-Chao Liu, Huan-Tang Lin, Shu‐Fu Lin, et al.
Oncotarget (2017) Vol. 8, Iss. 45, pp. 78429-78451
Open Access | Times Cited: 35
Sex disparities in thyroid cancer: a SEER population study
Peng Li, Ying Ding, Mengyuan Liu, et al.
Gland Surgery (2021) Vol. 10, Iss. 12, pp. 3200-3210
Open Access | Times Cited: 25
Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
Jinkui Wang, Chenghao Zhanghuang, Liming Jin, et al.
BMC Geriatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Development and validation of a nomogram to predict cancer-specific survival in middle-aged patients with papillary thyroid cancer: A SEER database study
Jie Tang, Chenghao Zhanghuang, Zhigang Yao, et al.
Heliyon (2023) Vol. 9, Iss. 2, pp. e13665-e13665
Open Access | Times Cited: 10
Predicting factors and clinical outcome of biochemical incomplete response in middle eastern differentiated thyroid carcinoma
Sandeep Kumar Parvathareddy, Abdul K. Siraj, Saeeda O. Ahmed, et al.
Endocrine (2024) Vol. 86, Iss. 1, pp. 268-275
Open Access | Times Cited: 3
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer
Francesca Ragusa, Silvia Martina Ferrari, Giusy Elia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5731-5731
Open Access | Times Cited: 15
Male sex is not an independent risk factor for recurrence of differentiated thyroid cancer: a propensity score-matching study
Joonseon Park, Kwangsoon Kim, Dong‐Jun Lim, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Secular Trends in the Epidemiologic Patterns of Thyroid Cancer in China Over Three Decades: An Updated Systematic Analysis of Global Burden of Disease Study 2019 Data
Yongze Li, Jianming Piao, Min Li
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 19
Recommend with caution: A meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance
Peter P. Issa, Ruhul Munshi, Aaron L. Albuck, et al.
American Journal of Otolaryngology (2023) Vol. 44, Iss. 6, pp. 103994-103994
Closed Access | Times Cited: 7
Tyrosine kinase inhibitors in iodine-refractory differentiated thyroid cancer: experience in clinical practice
María Molina‐Vega, Jorge Garcı́a-Alemán, Arántzazu Sebastián-Ochoa, et al.
Endocrine (2017) Vol. 59, Iss. 2, pp. 395-401
Closed Access | Times Cited: 22
Assessing radioiodine therapy long-term outcomes in differentiated thyroid cancer using nomograms
Sakhr Alshwayyat, Ashaar Al-Akhras, Alina Ghazou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival
Charles Marcus, Alexander Antoniou, Arman Rahmim, et al.
Journal of Medical Imaging and Radiation Oncology (2015) Vol. 59, Iss. 3, pp. 281-288
Closed Access | Times Cited: 20
Do Molecular Profiles of Primary Versus Metastatic Radioiodine Refractory Differentiated Thyroid Cancer Differ?
Cristiane Gomes-Lima, Leila Shobab, Di Wu, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 15
Male Sex Is an Independent Predictor of Recurrence-Free Survival in Middle Eastern Papillary Thyroid Carcinoma
Abdul K. Siraj, Sandeep Kumar Parvathareddy, Padmanaban Annaiyappanaidu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 10
Predictors of Recurrence in Patients with Papillary Thyroid Carcinoma: Does Male Sex Matter?
Hyeji Kim, Hyungju Kwon, Byung‐In Moon
Cancers (2022) Vol. 14, Iss. 8, pp. 1896-1896
Open Access | Times Cited: 10
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study
Yike Li, Yinqiong Huang, Xue He, et al.
Therapeutic Advances in Endocrinology and Metabolism (2022) Vol. 13
Open Access | Times Cited: 10
New insights in risk stratification of differentiated thyroid cancer
Maria Papaleontiou, Megan R. Haymart
Current Opinion in Oncology (2013) Vol. 26, Iss. 1, pp. 1-7
Open Access | Times Cited: 18
Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?
Aleksandra Gajowiec, Anna Chromik, Kinga Furga, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2438-2438
Open Access | Times Cited: 14
HS3ST3A1 and CAPN8 Serve as Immune-Related Biomarkers for Predicting the Prognosis in Thyroid Cancer
Zhao-Hui Chen, Hao-Ran Yue, Jun-Hui Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 9
Follicular Thyroid Carcinoma - Clinical and Diagnostic Findings in a 20-Year Follow Up Study
Claudiu-Iulian Bădulescu, Doina Piciu, Dragoș Apostu, et al.
Acta Endocrinologica (Bucharest) (2020) Vol. 16, Iss. 2, pp. 170-177
Open Access | Times Cited: 14
Progression of incidence and estimate of net survival from papillary thyroid cancers diagnosed between 2008 and 2016 in France
Marc Colonna, Françoise Borson‐Chazot, Patricia Delafosse, et al.
Annales d Endocrinologie (2020) Vol. 81, Iss. 6, pp. 530-538
Closed Access | Times Cited: 14

Scroll to top